Month: May 2021

2024.07.17
Summary of the most important events and achievements of the Genomtec S.A.

2024.06.25
Webinar: Trends in the M&A Market Specific to In-Vitro Diagnostics | 27 June, 2024, 3:00 p.m. (CEST)

2024.04.22
Dr. Trevor Hawkins, a distinguished entrepreneur, scientist, and leader with experience in global healthcare companies, has joined the Supervisory Board of Genomtec S.A.

2024.03.26
Genomtec secures PLN 10.6 million to fund scientific research and development of the oncology project - Company will raise capital from founding shareholders and investors

2024.03.26
Genomtec strengthens the Supervisory Board with individuals who bring extensive industry and business experience

Archive

2021.05.31

Genomtec strengthens the management board – Charudutt Shah joins the company

Genomtec SA announced that Charudutt Shah is joining the board. The newly appointed member of the Genomtec board is a senior executive with many ...
Read
2021.05.27

Genomtec expands patient group in the additional comparative study of its COVID-19 test directly from saliva

Genomtec S.A. will conduct additional comparative study of its test detecting SARS-CoV-2 directly from saliva sample utilizing the Direct-RT-LAMP ...
Read
2021.05.17

Genomtec launches the world’s first genetic diagnostic test for the detection of SARS-CoV-2 directly from a saliva sample

Genomtec S.A., listed on the NewConnect market at Warsaw Stock Exchange, a company developing medical technology applicable in segment of ...
Read
2021.05.10

Genomtec receives the third patent based on the LAMP technique

Company has been granted a patent protection from the Patent Office of the Republic of Poland for a set of primers amplifying Borrelia ...
Read

Archive